Xenetic Biosciences (XBIO) CEO Jeffrey Eisenberg – Presentation from NobleCon17
Автор: channelchek
Загружено: 2021-02-12
Просмотров: 339
Описание:
Xenetic Biosciences CEO Jeffrey Eisenberg’s presentation from NobleCon17, January 2021. Following a formal presentation, Jeffrey is joined by Noble Capital Markets Senior Research Analyst Ahu Demir, PhD for a Q&A session, featuring questions submitted by the NobleCon live audience.
More information on Xenetic Biosciences, including recent news and advanced market data is available (at no cost) at https://www.channelchek.com/company/XBIO
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
